Adrian Kilcoyne
Chief Tech/Sci/R&D Officer chez CELULARITY INC.
Fortune : 586 932 $ au 31/03/2024
Profil
Adrian Kilcoyne is currently the Chief Medical Officer & Executive Vice President at Celularity, Inc. Prior to this, he worked as the VP, Head-US Medical Affairs & Health Economics at AstraZeneca PLC.
He also served as the Chief Medical Officer at Humanigen, Inc. from 2021 to 2022.
Dr. Kilcoyne has a graduate degree from Warwick Business School and the University of London.
He also holds a doctorate degree from Trinity College Dublin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CELULARITY INC. CLASS A
0,52% | 17/02/2024 | 112 224 ( 0,52% ) | 586 932 $ | 31/03/2024 |
Postes actifs de Adrian Kilcoyne
| Sociétés | Poste | Début |
|---|---|---|
| CELULARITY INC. | Chief Tech/Sci/R&D Officer | 03/10/2022 |
Anciens postes connus de Adrian Kilcoyne
| Sociétés | Poste | Fin |
|---|---|---|
| HUMANIGEN, INC. | Chief Tech/Sci/R&D Officer | 28/09/2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Formation de Adrian Kilcoyne
| Warwick Business School | Graduate Degree |
| University of London | Graduate Degree |
| Trinity College Dublin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| HUMANIGEN, INC. | Health Technology |
| CELULARITY INC. | Commercial Services |
